Re: BREASTHEALTH: molecular breast imaging or MBI - dense breast tissue
From: Hope Waltman (anonymous@obgyn.net)
Wed, 4 Mar 2009 06:59:49 -0600 (CST)
Seeing Breast Cancer Clearly
"Mammograms save lives, but for millions of women with dense breast
tissue, it's not enough. Doctors designed a new type of technology that
picks up the tumors mammograms miss.
A team of doctors at the Mayo Clinic developed a new form of tumor
detection called molecular breast imaging, or MBI. Women get an
injection of a radioactive tracer that travels to the tumor cells and
lights them up."
http://www.ivanhoe.com/channels/p_channelstory.cfm?storyid=20876
Best Regards, Hope Waltman, WHF Moderator
At Mon, 2 Mar 2009, Hope Waltman wrote:
>
>vhttp://www.obgyn.net/breast-care/breast-care.asp Breast Care Section
>
>New Test May Mean Faster Breast Cancer Treatment
>"FRIDAY, Feb. 27 (HealthDay News) -- A new genetic test that analyzes a
>set of 50 genes to identify four types of breast cancer could lead to
>quicker, more immediate treatment for patients, according to U.S.
>researchers who developed the test.
>
>Ellis and his colleagues analyzed the gene activity of more than 1,000
>breast tumors and identified 50 genes that could be used to identify
>each of the four types of breast tumors -- luminal A, luminal B,
>HER2-enriched and basal-like. A genetic test called OncotypeDx, which
>is currently in wide use, doesn't identify all four tumor types,
>according to background information in the news release.
>
>"Our test is the first to incorporate a molecular profile for the
>basal-like type breast cancers," Ellis said. "That's important because
>these breast cancers are arguably the most aggressive yet the most
>sensitive to chemotherapy. By identifying them, we can ensure they are
>treated adequately."
>
>The new test also identifies what's often considered a fifth breast
>cancer type, known as normal-like. But the researchers discovered that,
>instead of being a fifth type of breast cancer, normal-like is an
>indicator that a breast tumor sample contains insufficient tumor cells
>to make a molecular diagnosis and that a new sample needs to be taken.
>
>The study was published online Feb. 9 in the Journal of Clinical
>Oncology."
>
>http://www.nlm.nih.gov/medlineplus/news/fullstory_81148.html
>
>Best Regards, Hope Waltman, WHF Moderator
>http://www.hopeforfibroids.org